Deutsche Bank Ag\ Corbus Pharmaceuticals Holdings, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 04, 2021	SELL	$1.01 - $1.82 $54,548 - $98,294	-54,008 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$1.39 - $2.21 $19,049 - $30,288	-13,705 Reduced 20.24%	54,008 $98,000
Q1 2021 May 13, 2021	BUY	$1.27 - $3.42 $15,698 - $42,274	12,361 Added 22.33%	67,713 $133,000
Q4 2020 Feb 16, 2021	BUY	$0.94 - $1.89 $14,142 - $28,435	15,045 Added 37.33%	55,352 $70,000
Q3 2020 Nov 12, 2020	BUY	$1.5 - $9.38 $10,399 - $65,031	6,933 Added 20.77%	40,307 $72,000
Q2 2020 Aug 13, 2020	BUY	$4.79 - $8.39 $48,173 - $84,378	10,057 Added 43.13%	33,374 $280,000
Q1 2020 May 14, 2020	BUY	$3.44 - $7.21 $6,446 - $13,511	1,874 Added 8.74%	23,317 $122,000
Q4 2019 Feb 14, 2020	BUY	$4.29 - $5.64 $20,386 - $26,801	4,752 Added 28.47%	21,443 $117,000
Q3 2019 Nov 14, 2019	SELL	$4.87 - $7.08 $12,929 - $18,797	-2,655 Reduced 13.72%	16,691 $81,000
Q2 2019 Aug 14, 2019	SELL	$6.6 - $7.8 $302,247 - $357,201	-45,795 Reduced 70.3%	19,346 $132,000
Q1 2019 May 15, 2019	BUY	$5.76 - $8.95 $31,334 - $48,687	5,440 Added 9.11%	65,141 $451,000
Q4 2018 Feb 14, 2019	SELL	$5.26 - $7.97 $472,653 - $716,168	-89,858 Reduced 60.08%	59,701 $348,000
Q3 2018 Dec 21, 2021	BUY	$4.65 - $7.95 $99,342 - $169,843	21,364 Added 16.67%	149,559 $1.13 Million
Q3 2018 Nov 14, 2018	SELL	$4.65 - $7.95 $572,210 - $978,295	-123,056 Reduced 48.98%	128,195 $967,000
Q2 2018 Apr 21, 2020	BUY	$5.05 - $6.8 $119,018 - $160,262	23,568 Added 10.35%	251,251 $1.27 Million
Q2 2018 Aug 14, 2018	BUY	$5.05 - $6.8 $789,067 - $1.06 Million	156,251 Added 218.74%	227,683 $1.15 Million
Q1 2018 Oct 18, 2019	BUY	$5.6 - $9.25 $102,530 - $169,358	18,309 Added 34.47%	71,432 $434,000
Q1 2018 May 15, 2018	SELL	$5.6 - $9.25 $345,626 - $570,900	-61,719 Reduced 53.74%	53,123 $322,000
Q4 2017 Feb 14, 2018	BUY	$6.6 - $7.78 $262,482 - $309,410	39,770 Added 52.98%	114,842 $814,000
Q3 2017 Nov 14, 2017	BUY	$5.75 - $7.75 $431,664 - $581,808	75,072	75,072 $535,000

Others Institutions Holding CRBP

# of Institutions

Shares Held

38.7K

Call Options Held

Put Options Held

Kingsbury Capital Investment Advisors LLC Evanston, IL

33.7K
Shares

$559,757
0.01% of portfolio
Exane Derivatives

2.65K
Shares

$44,016
0.0% of portfolio
American Portfolios Advisors Holbrook, NY

2.31K
Shares

$38,402
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About Corbus Pharmaceuticals Holdings, Inc.

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $2.08B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

More about CRBP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account